NASDAQ: CBRSCerebras Systems Inc Stock
$181.21-10.72 (-5.59%)
Updated Sep 14, 2026
CBRS Price
$181.21
Fair Value Price
N/A
Market Cap
$43.05B
52 Week Low
$160.81
52 Week High
$386.34
P/E
N/A
P/B
4.7x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.27
Operating Cash Flow
N/A
Beta
3.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CBRS Overview
Cerebras Systems Inc. is a leading innovator in artificial intelligence infrastructure. The company develops and manufactures an advanced AI compute platform, integrating proprietary hardware systems and software. This platform is delivered in rack-mountable units, suitable for deployment in data centers, scaling all the way up to supercomputer-level capabilities. At its core is the groundbreaking Wafer-Scale Engine (WSE), a unique chip that encompasses an entire silicon wafer. This innovation is specifically engineered to deliver superior performance and speed compared to conventional GPUs, addressing the intensive computational demands of inference, Generative AI, and a broad spectrum of other AI applications. Cerebras serves a diverse clientele, including leading hyperscalers, advanced foundation model laboratories, AI-native and digital-first businesses, large enterprises, and key players in Sovereign AI initiatives. With operations spanning the United States, Europe, the Middle East, Africa, and other international markets, Cerebras maintains a significant global footprint. The company was established in 2015 and is headquartered in Sunnyvale, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CBRS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important CBRS news, forecast changes, insider trades & much more!
CBRS News
Overview
Due Diligence Score
–
Industry Average (38)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBRS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CBRS is good value based on its book value relative to its share price (4.7x), compared to the US Semiconductors industry average (11.38x)
P/B vs Industry Valuation
CBRS's short-term assets ($9.12B) exceed its short-term liabilities ($1.57B)
Short-term Liabilities Financials
CBRS's short-term assets ($9.12B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more CBRS due diligence checks available for Premium users.
Valuation
CBRS fair value
Fair Value of CBRS stock based on Discounted Cash Flow (DCF)
Price
$181.21
Fair Value
-$224.34
Undervalued by
180.77%
CBRS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.7x
Industry
11.38x
CBRS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CBRS's financial health
Profit margin
Revenue
$180.1M
Net Income
-$450.5M
Profit Margin
-250.1%
Assets to liabilities
Assets
$11.6B
Liabilities
$2.5B
Debt to equity
0.27
CBRS's short-term assets ($9.12B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBRS's short-term assets ($9.12B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBRS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$59.8M
Investing
-$1.1B
Financing
$5.8B
CBRS vs Semiconductor Stocks
Cerebras Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.